reference/22856505

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22856505

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Clinical Trial, Phase II\|Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
issn	1932-6203
issueIdentifier	10
pageRange	e76829-
publicationName	PLoS ONE
startingPage	e76829
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_35ec2a2eac8d54867b076dc24e6392bc http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c563f88f898eb2490ef734a376126b75 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_40080405907a212c9339451a2715d255 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_857cf166a748e849f3175a1ff6db070c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_749ec21df8858ea4e3c188303fa5c770 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c7a085eb9cd8fd2b0e868d3183147469
bibliographicCitation	Ibarrondo FJ, Yang OO, Chodon T, Avramis E, Lee Y, Sazegar H, Jalil J, Chmielowski B, Koya RC, Schmid I, Gomez-Navarro J, Jamieson BD, Ribas A, Comin-Anduix B. Natural Killer T Cells in Advanced Melanoma Patients Treated with Tremelimumab. PLoS ONE. 2013 Oct 22;8(10):e76829. doi: 10.1371/journal.pone.0076829.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e17bd729f1772f2e39570e808a78f499 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0019016a8f99f20e5b45908013aa39f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08a1b9c856ab3396bbfe7535946dfc40 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c4129b03bcd80ef44a4d5e4a00502fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23e1a400f7009281134e021e2de281e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6eb583ea0a231440036ab95f906f53d5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23c7d021297fa5081172a3d1b35a7d91 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c6441d37b0c89431ac635cc17678c9a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e05188886ecdd871c8596bc546d73e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b95f635c039b278c94c519ad71dc7349 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec2718c89fa569ee889a7baee3455504 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9355237dedbfaeb3da1f4ca0fda89b3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_667f95fc8d8f08f8b8b00296a0a3e2ed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db4f8ee255779c1779eef7f499e58e55
date	2013-10-22^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/24167550 https://doi.org/10.1371/journal.pone.0076829 https://pubmed.ncbi.nlm.nih.gov/PMC3805549
isPartOf	https://portal.issn.org/resource/ISSN/1932-6203 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33103
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Natural Killer T Cells in Advanced Melanoma Patients Treated with Tremelimumab
discusses	http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0545549 http://id.nlm.nih.gov/mesh/M0519601 http://id.nlm.nih.gov/mesh/M0556300
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008545Q000276 http://id.nlm.nih.gov/mesh/D008545Q000188 http://id.nlm.nih.gov/mesh/D000911Q000008 http://id.nlm.nih.gov/mesh/D058965Q000008 http://id.nlm.nih.gov/mesh/D055611Q000276 http://id.nlm.nih.gov/mesh/D000970Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D018417Q000276 http://id.nlm.nih.gov/mesh/D018414Q000276 http://id.nlm.nih.gov/mesh/D007111Q000187 http://id.nlm.nih.gov/mesh/D018418Q000276
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3180f3560c702ffddc361716fecd9861 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_69166afc123a2ea4b88d871f79419435 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e

Showing number of triples: 1 to 63 of 63.